Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis


BOZ C., TERZİ M., Ozer B., Turkoglu R., KARABUDAK R., EFENDİ H. , ...More

MULTIPLE SCLEROSIS AND RELATED DISORDERS, vol.36, 2019 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 36
  • Publication Date: 2019
  • Doi Number: 10.1016/j.msard.2019.101376
  • Title of Journal : MULTIPLE SCLEROSIS AND RELATED DISORDERS

Abstract

Background: Fingolimod and teriflunomide are commonly used in the treatment of relapsing-remitting multiple sclerosis (RRMS). These have not been compared in controlled trials, but only in observational studies, with inconclusive results. Comparison of their effect on relapse and disability in a real-world setting is therefore needed.